Human IFITM1 protein (Recombinant) (N-GST & C-His) (STJP016087)

SKU:
STJP016087
£222.50 - £1,177.50
Free Shipping
Processing The item has been added

Host: E.coli
Applications: ELISA/Immunogen/SDS-PAGE/WB
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description : Recombinant-Human IFITM1-N-GST & C-His protein was developed from e.coli and has a target region of N-GST & C-His. For use in research applications.
Formulation: Lyophilized from a solution in PBS pH 7.4, 1 mM EDTA, 4% Trehalose, 1% Mannitol.
Dilution Range: Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.
Storage Instruction: Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at-20 to-80°C for twelve months from the date of receipt.
Endotoxin: Please contact us for further information.
Gene Symbol: IFITM1
Gene ID: 8519
Uniprot ID: IFM1_HUMAN
Immunogen Region: His2-His36&Ala58-Asn86&Ser108-Tyr125
Immunogen: Homo sapiens (Human)
Post Translational Modifications Palmitoylation on membrane-proximal cysteines controls clustering in membrane compartments and antiviral activity.
Function IFN-induced antiviral protein which inhibits the entry of viruses to the host cell cytoplasm, permitting endocytosis, but preventing subsequent viral fusion and release of viral contents into the cytosol. Active against multiple viruses, including influenza A virus, SARS coronaviruses (SARS-CoV and SARS-CoV-2), Marburg virus (MARV), Ebola virus (EBOV), Dengue virus (DNV), West Nile virus (WNV), human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV). Can inhibit: influenza virus hemagglutinin protein-mediated viral entry, MARV and EBOV GP1,2-mediated viral entry and SARS-CoV and SARS-CoV-2 S protein-mediated viral entry. Also implicated in cell adhesion and control of cell growth and migration. Inhibits SARS-CoV-2 S protein-mediated syncytia formation. Plays a key role in the antiproliferative action of IFN-gamma either by inhibiting the ERK activation or by arresting cell growth in G1 phase in a p53-dependent manner. Acts as a positive regulator of osteoblast differentiation. In hepatocytes, IFITM proteins act in a coordinated manner to restrict HCV infection by targeting the endocytosed HCV virion for lysosomal degradation. IFITM2 and IFITM3 display anti-HCV activity that may complement the anti-HCV activity of IFITM1 by inhibiting the late stages of HCV entry, possibly in a coordinated manner by trapping the virion in the endosomal pathway and targeting it for degradation at the lysosome.
Protein Name Interferon-Induced Transmembrane Protein 1
Dispanin Subfamily A Member 2a
Dspa2a
Interferon-Induced Protein 17
Interferon-Inducible Protein 9-27
Leu-13 Antigen
Cd Antigen Cd225
Database Links Reactome: R-HSA-198933
Reactome: R-HSA-909733
Cellular Localisation Cell Membrane
Single-Pass Membrane Protein
Lysosome Membrane
Alternative Protein Names Interferon-Induced Transmembrane Protein 1 protein
Dispanin Subfamily A Member 2a protein
Dspa2a protein
Interferon-Induced Protein 17 protein
Interferon-Inducible Protein 9-27 protein
Leu-13 Antigen protein
Cd Antigen Cd225 protein
IFITM1 protein
CD225 protein
IFI17 protein

Information sourced from Uniprot.org